Indian pharma industry headwinds in remission: ICRA
New Delhi: ICRA expects the revenues of the sample set of 25 Indian pharmaceutical companies (which account for ~60 per cent of the overall Indian pharmaceutical industry) to grow by 7-9 per…
NLEM: Anti-diabetes drugs and patented antivirals to get cheaper
Since the government announced the release of the most recent National List of Essential Medicines (NLEM), several commonly used medications are expected to become less expensive, including: Diabetes medications, Patented antivirals used…
No Side Effects Of Drugs Dropped From NLEM In 2022: Experts
New Delhi : Ensuring better healthcare facilities for the people of the country is the responsibility of the state, wherein drugs play a pivotal role. And to regulate the drugs to…
